The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Recombinant DNA Technology Market Evolve From 2026 To 2030?
The recombinant dna technology market has experienced substantial growth in recent years. It is forecast to grow from $913.42 billion in 2025 to $998.83 billion in 2026, at a compound annual growth rate (CAGR) of 9.4%. Historically, this expansion can be attributed to the broadening of molecular biology research, an increasing incidence of chronic diseases, advancements in biologics development, rising academic and government research funding, and the early commercialization of recombinant therapies.
The recombinant DNA technology market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $1414.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This expected growth during the forecast period stems from factors such as increasing investments in gene therapy development, a rising demand for personalized medicine, the broader application of CRISPR-based technologies, a growing emphasis on sustainable bioproduction, and enhanced collaboration between academic and industrial sectors. Prominent trends observed within this forecast timeframe include the increasing adoption of gene editing platforms, accelerated development of recombinant vaccines, wider use of advanced expression systems, the expansion of cell and and gene therapy pipelines, and an enhanced focus on scalable biomanufacturing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Recombinant DNA Technology Market?
The increasing development of genetically modified crops is expected to propel the growth of the recombinant DNA technology market going forward. Genetically modified crops refer to plants whose genetic makeup has been intentionally altered using biotechnological techniques. Recombinant DNA technology is employed in GM crops through a multi-step process that involves isolating genes for desired traits, constructing recombinant DNA, introducing it into host crop cells, selecting and screening for successful integration, regenerating transgenic plants, testing for trait expression, conducting field trials, obtaining regulatory approval, and ultimately commercializing crops with improved characteristics. For instance, in December 2023, the United States Department of Agriculture reported that Canada planted 11.7 million hectares of genetically engineered crops, primarily consisting of canola, soybeans, and corn. This marked a 4% increase from 2022, driven by the expansion of canola planting areas. Therefore, the increasing development of genetically modified crops is driving the growth of the recombinant DNA technology market.
Which Segment Areas Are Covered In The Recombinant DNA Technology Market Analysis?
The recombinant dna technology market covered in this report is segmented –
1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types
Subsegments:
1) By Recombinant Protein Drugs: Hormones, Growth Factors
2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines
3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop
4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems
5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies
6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)
What Key Developments And Trends Are Impacting The Recombinant DNA Technology Market?
Leading companies operating in the recombinant DNA technology market are increasingly adopting advanced gene-editing techniques, specifically CRISPR-based recombinant DNA engineering, to boost precision, therapeutic effectiveness, and targeted genome alterations. This CRISPR-based recombinant DNA engineering constitutes a molecular method that utilizes a guide RNA and the Cas9 enzyme to identify and cleave specific DNA sequences, thereby enabling functions such as precise gene correction, controlled DNA insertion, and efficient genomic manipulation. For example, in December 2023, Vertex Pharmaceuticals, a US-based biotechnology company, alongside CRISPR Therapeutics, a Switzerland-based gene-editing biotechnology company, secured approval from the US Food and Drug Administration for Casgevy. This CRISPR-enabled recombinant DNA therapy is formulated for the treatment of sickle cell disease and transfusion-dependent beta thalassemia by editing a patient’s own stem cells to elevate fetal hemoglobin production. Casgevy offers targeted DNA cleavage, high-fidelity gene modification, and ex vivo cell processing. The therapy improves patient outcomes by facilitating durable gene correction, decreasing reliance on conventional treatments, and supporting long-term clinical advantages.
Which Global Companies Are Actively Competing In The Recombinant DNA Technology Market?
Major companies operating in the recombinant dna technology market are Profacgen BioTech Corp, Amgen Inc, Novartis International AG, GenScript Biotech Corporation, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A, Merck & Co. Inc, Biogen Inc, GlaxoSmithKline PLC, New England Biolabs Inc, Bayer CropScience, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, Gilead Sciences Inc, Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc, bluebird bio Inc, Lonza Group AG, Horizon Discovery Group PLC, Sarepta Therapeutics Inc, Sangamo Therapeutics Inc
Read the full recombinant dna technology market report here:
https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report
What Are The Leading Geographic Regions In The Recombinant DNA Technology Market?
North America was the largest region in the recombinant DNA technology market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Recombinant DNA Technology Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8233&type=smp
Browse Through More Reports Similar to the Global Recombinant DNA Technology Market 2026, By The Business Research Company
Plasmid Dna Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report
Gene Delivery Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Dna Digital Data Storage Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-digital-data-storage-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model